Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2021

Total Assets: $921.5M

Liabilities Breakdown FY2021

Total Liabilities: $242.6M